More articles from Editorial

  • The estimated glomerular filtration rate as a test for chronic kidney disease: Problems and solutions
    Andrew D. Rule, MD and John C. Lieske, MD
    Cleveland Clinic Journal of Medicine March 2011, 78 (3) 186-188; DOI: https://doi.org/10.3949/ccjm.78a.11004

    Creatinine-based testing is not perfect. Perhaps a two-step approach would be better.

  • Intracerebral hemorrhage: Pick your poison
    Franklin Michota, MD, FHM
    Cleveland Clinic Journal of Medicine November 2010, 77 (11) 743-746; DOI: https://doi.org/10.3949/ccjm.77a.10103

    Whether to resume anticoagulant therapy after an intracerebral hemorrhage requires careful consideration of many factors, including patient preferences and tolerance of different levels of risk.

  • Is there a doctor in your house? Home health care of the future
    John Hickner, MD, MSc
    Cleveland Clinic Journal of Medicine October 2010, 77 (10) 681-682; DOI: https://doi.org/10.3949/ccjm.77a.10100

    A modernized, efficient, effective home health care system would be a welcome improvement on the patchwork system we have had for the past 30 years.

  • Timeliness of treatment is more important than choice of reperfusion therapy
    Eric R. Bates, MD
    Cleveland Clinic Journal of Medicine September 2010, 77 (9) 567-569; DOI: https://doi.org/10.3949/ccjm.77a.10085

    The most important modifiable predictor of outcome in ST-segment elevation MI is the time to treatment, a biological truth that continues to be supported by clinical evidence.

  • Stenting for atherosclerotic renal artery stenosis: One poorly designed trial after another
    Mitchell D. Weinberg, MD and Jeffrey W. Olin, DO
    Cleveland Clinic Journal of Medicine March 2010, 77 (3) 164-171; DOI: https://doi.org/10.3949/ccjm.77a.10001

    The three randomized trials of stenting vs medical therapy published so far are so seriously flawed that it is impossible to make treatment decisions based on their results.

  • Treating the renal patient who has a fracture: Opinion vs evidence
    Maria Coco, MD, MS
    Cleveland Clinic Journal of Medicine December 2009, 76 (12) 684-688; DOI: https://doi.org/10.3949/ccjm.76a.09075

    The patient with chronic renal disease who has a fracture remains a unique management challenge. Opinions on treatment abound, but without adequate evidence to back them up.

  • Should catheter ablation be the first line of treatment for atrial fibrillation?
    Bruce D. Lindsay, MD
    Cleveland Clinic Journal of Medicine September 2009, 76 (9) 503-506; DOI: https://doi.org/10.3949/ccjm.76a.09070

    Antiarrhythmic drugs should remain the first line of treatment until trials prove otherwise.

  • The new data on prostate cancer screening: What should we do now?
    Timothy Gilligan, MD, MS
    Cleveland Clinic Journal of Medicine August 2009, 76 (8) 446-448; DOI: https://doi.org/10.3949/ccjm.76a.09079

    Does screening have a benefit? We have new data, but do we have the answer?

  • Advance care planning is an art, not an algorithm
    David Grossman, MD
    Cleveland Clinic Journal of Medicine May 2009, 76 (5) 287-288; DOI: https://doi.org/10.3949/ccjm.76a.08109
  • Evolution and results of aortic valve surgery, and a ‘disruptive’ technology
    Lars G. Svensson, MD, PhD
    Cleveland Clinic Journal of Medicine November 2008, 75 (11) 802-804;

    Percutaneous aortic valve insertion is already benefitting patients who would not be able to undergo open heart surgery for valve replacement. However, the technology is still so new that we do not yet know how to define who will benefit from it.

Pages